Search

Hani Sabbah Phones & Addresses

  • Waterford, MI
  • Union Lake, MI
  • 8385 Wood Shadows Ln, Cordova, TN 38018 (901) 753-7708 (901) 753-9143
  • 1001 Clusterwood Dr, Yalaha, FL 34797 (352) 324-4133
  • White Lake, MI
  • Memphis, TN

Publications

Us Patents

Partial Fatty Acid Oxidation Inhibitors In The Treatment Of Congestive Heart Failure

View page
US Patent:
6528511, Mar 4, 2003
Filed:
Feb 15, 2001
Appl. No.:
09/784559
Inventors:
Andrew A. Wolff - San Francisco CA
Brent Blackburn - Los Altos CA
Hani Naief Sabbah - Waterford MI
William Clark Stanley - Shaker Heights OH
Assignee:
CV Therapeutics, Inc. - Palo Alto CA
International Classification:
A61K 31495
US Classification:
51425212
Abstract:
Methods are disclosed for treating congestive heart failure with partial inhibitors of fatty acid oxidation. The compounds increase cardiac performance without affecting heart rate, blood pressure, or oxygen consumption.

Cardiac Disease Treatment Method

View page
US Patent:
6582355, Jun 24, 2003
Filed:
May 4, 2000
Appl. No.:
09/565041
Inventors:
Clifton A. Alferness - Redmond WA
Hani N. Sabbah - Waterford MI
Assignee:
Acorn Cardiovascular, Inc. - St. Paul MN
International Classification:
A61F 204
US Classification:
600 37
Abstract:
A jacket of biological compatible material has an internal volume dimensioned for an apex of the heart to be inserted into the volume and for the jacket to be slipped over the heart. The jacket has a longitudinal dimension between upper and lower ends sufficient for the jacket to surround a lower portion of the heart with the jacket surrounding a valvular annulus of the heart and further surrounding the lower portion to cover at least the ventricular lower extremities of the heart. The jacket is adapted to be secured to the heart with the jacket surrounding at least the valvular annulus and the ventricular lower extremities. The jacket is adjustable on the heart to snugly conform to an external geometry of the heart and assume a maximum adjusted volume for the jacket to constrain circumferential expansion of the heart beyond the maximum adjusted volume during diastole and to permit unimpeded contraction of the heart during systole.

Partial Fatty Acid Oxidation Inhibitors In The Treatment Of Congestive Heart Failure

View page
US Patent:
6677342, Jan 13, 2004
Filed:
Aug 27, 2002
Appl. No.:
10/228573
Inventors:
Andrew A. Wolff - San Francisco CA
Brent Blackburn - Los Altos CA
Hani Naief Sabbah - Waterford MI
William Clark Stanley - Shaker Heights OH
Assignee:
CV Therapeutics, Inc. - Palo Alto CA
International Classification:
A61K 31495
US Classification:
51425212
Abstract:
Methods are disclosed for treating congestive heart failure with partial inhibitors of fatty acid oxidation. The compounds increase cardiac performance without affecting heart rate, blood pressure, or oxygen consumption.

Cardiac Disease Treatment And Device

View page
US Patent:
6730016, May 4, 2004
Filed:
Jun 12, 2000
Appl. No.:
09/591875
Inventors:
James Cox - Hamel MN
Michael J. Girard - Lino Lakes MN
Donald G. Rohrbaugh - Minnetonka MN
Hani N. Sabbah - Waterford MI
Robert G. Walsh - Lakeville MN
Assignee:
Acorn Cardiovascular, Inc. - St. Paul MN
International Classification:
A61F 200
US Classification:
600 37
Abstract:
A device for treating cardiac disease of a heart having an upper portion and a lower portion divided by an A-V groove, the device including a jacket adapted to be secured to the heart, and a non-adherent material in association with the jacket. The jacket is fabricated from a flexible material defining a volume between an upper and a lower end, the jacket being adapted to be adjusted on the heart to snugly conform to an external geometry of the heart and assume a maximum adjusted volume for the jacket to constrain expansion of the heart beyond the maximum adjusted volume during diastole and permit substantially unimpeded contraction of the heart during systole. As a result of the flexible material, the jacket allows unimpeded diastolic filling of the heart. Also described is a method for treating cardiac disease including surgically accessing the heart, applying the treatment device of the invention, securing the treatment device to the heart, and surgically closing access to the heart while leaving the treatment device on the heart.

Cardiac Disease Treatment And Device

View page
US Patent:
7326174, Feb 5, 2008
Filed:
May 4, 2004
Appl. No.:
10/839724
Inventors:
James Cox - Hamel MN, US
Michael J. Girard - Lino Lakes MN, US
Donald G. Rohrbaugh - Minnetonka MN, US
Hani N. Sabbah - Waterford MI, US
Robert G. Walsh - Lakeville MN, US
Assignee:
Acorn Cardiovascular, Inc. - St. Paul MN
International Classification:
A61F 13/00
A61F 2/00
US Classification:
600 37
Abstract:
A device for treating cardiac disease of a heart having an upper portion and a lower portion divided by an A-V groove, the device including a jacket adapted to be secured to the heart, and a non-adherent material in association with the jacket. The jacket is fabricated from a flexible material defining a volume between an upper and a lower end, the jacket being adapted to be adjusted on the heart to snugly conform to an external geometry of the heart and assume a maximum adjusted volume for the jacket to constrain expansion of the heart beyond the maximum adjusted volume during diastole and permit substantially unimpeded contraction of the heart during systole. As a result of the flexible material, the jacket allows unimpeded diastolic filling of the heart. Also described is a method for treating cardiac disease including surgically accessing the heart, applying the treatment device of the invention, securing the treatment device to the heart, and surgically closing access to the heart while leaving the treatment device on the heart.

Method Of Improving Cardiac Function Of A Diseased Heart

View page
US Patent:
7658951, Feb 9, 2010
Filed:
Nov 3, 2003
Appl. No.:
10/700032
Inventors:
Hani N. Sabbah - Waterford MI, US
Viktor G. Sharov - Centennial CO, US
Yukata Ishigai - Ichikawa, JP
Victor A. Maltsev - Parkville MD, US
Assignee:
Henry Ford Health System - Detroit MI
International Classification:
A61K 35/28
C12N 5/06
C12N 5/08
US Classification:
424577, 424520, 435372
Abstract:
A method of treating heart failure and improving cardiac function by administering stem cell products to a heart in need of treatment, whereby the stem cell products improve cardiac muscle function thereby treating heart failure and improving cardiac function. A method of enriching or regenerating damaged myocardium by administering stem cell products to damaged myocardium. Stem cell products for use in treating heart failure are also provided. A composition for enriching and regenerating damaged myocardium, the composition having stem cell products in a pharmaceutically acceptable carrier.

Apparatus And Method For Delivering Electrical Signals To Modify Gene Expression In Cardiac Tissue

View page
US Patent:
7840262, Nov 23, 2010
Filed:
Mar 10, 2004
Appl. No.:
10/549216
Inventors:
Yuval Mika - Zichron-Yaakov, IL
Hani N. Sabbah - Detroit MI, US
Walid Haddad - Closter NJ, US
Benny Rousso - Rishon-Lezion, IL
Assignee:
Impulse Dynamics NV - Curacao
International Classification:
A61N 1/00
US Classification:
607 2, 607 3
Abstract:
Method and apparatus () for modifying gene expression in cardiac muscle cells (), by the application of electric fields.

Cardiac Repair, Resizing And Reshaping Using The Venous System Of The Heart

View page
US Patent:
7875017, Jan 25, 2011
Filed:
Apr 10, 2008
Appl. No.:
12/082368
Inventors:
Hani N. Sabbah - Waterford MI, US
Assignee:
Henry Ford Health System - Detriot MI
International Classification:
A61M 31/00
US Classification:
604508, 604 57
Abstract:
Structurally supportive material is implanted or injected into cardiac veins as discrete masses at various sites in the cardiac venous system to reinforce the myocardium for the purpose of preventing, moderating, stopping or reversing negative cardiac remodeling due to various adverse cardiac conditions, both acute and chronic, or for the purpose of treating localize anomalies of the heart, or for both purposes. The sites may be arranged in a pattern about one or more chambers of the heart such that the masses cooperatively reduce stress in the chamber wall and reduce chamber size. Some patterns also cause a beneficial global reshaping of the chamber. These changes occur quickly and are sustainable, and have a rapid and sustainable therapeutic effect on cardiac function. Patterns of distribution of discrete masses in the heart for global resizing and reshaping may also be used as is or augmented by supplemental patterns to treat localized conditions such as myocardial infarctions and overt aneurysm of the ventricular wall as typically forms in response to large transmural myocardial infarctions. These techniques may also be used to treat localized conditions that may not yet have progressed to cardiomyopathy.
Hani N Sabbah from Waterford, MI, age ~74 Get Report